| Code | 3729C | ||||||||||
| MA number | 44/0177/13-S | ||||||||||
| Product Form: | sol ijf 1x40 ml (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Subcutaneous and intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 10.06.2013 |
| Pediatric indication: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Cytarabine Accord 100 mg_ml injekčný_infúzny roztok_01.2026.pdf
|
| PIL: |
PIL_Cytarabine Accord 100 mg_ml injekčný_infúzny roztok_01.2026.pdf
|
| Safety feature | Yes |
| Data update: | 12.01.2026 |
